Racine attends the Society of Toxicology General Meeting in San Antonio, Texas

by M. Allison Wolf

Chris Racine, Ph.D. student, on far leftBiomedical Sciences Ph.D. student Chris Racine recently presented his research at the Society of Toxicology (SOT) General Meeting in San Antonio, Texas. The study Chris presented at this meeting was entitled “Role of renal cytochrome p450 isozymes in the bioactivation of 3,5-dichloroaniline in vitro.” The long term goal of this project is “to determine the biotransformation of 3,5-dichloroaniline (3,5-DCA), mechanisms for bioactivation of 3,5-DCA to nephrotoxic species by the kidney, and if gender differences exist in the susceptibility of the kidney to the toxic effects of 3,5-DCA.”   

The SOT conference, which was held from March 10-14, is the largest toxicology meeting in the world and it brings together scientist in academia, government, and industry from various countries. Dr. Gary Rankin, Chris Racine’s Ph.D. advisor said that, “It is important for students to experience the scientific exchange that happens at a national research conference. There is no substitute for attending such a meeting in person. The meeting also gives the advisor the opportunity to introduce the students to other top scientists and students in their field, and the feedback received at a national presentation can be very helpful for the student’s research projects.”

Congratulations, Chris!

BMS researchers present at international scientific meetings

HUNTINGTON, W.Va. – Marshall University biomedical sciences researchers are presenting their work in the fields of toxicology and cancer biology at international scientific meetings this month and in April.

Monica Valentovic, Ph.D.Dr. Monica Valentovic, a professor in the Department of Pharmacology, Physiology and Toxicology, presented at last week’s Society of Toxicology Annual Meeting in San Francisco. Her talk focused on her lab’s work to evaluate ways to reduce the side effects of cancer chemotherapeutic drugs.

Mike Brown, a biomedical sciences doctoral candidate working in Valentovic’s lab, also presented at the conference. He discussed his research examining ways to reduce liver damage caused by acetaminophen use.

In addition, Valentovic served as chairman of the meeting’s Renal Toxicology Session.

The conference is the largest toxicology meeting and exhibition in the world, with attendance of more than 7,500 scientists from academia, government and industry from around the globe.

Another biomedical sciences doctoral candidate, Johannes Fahrmann, will be presenting his research to explore the effects of omega-3 fatty acids in early stage chronic lymphocytic leukemia at next month’s Experimental Biology conference in San Diego.

W. Elaine Hardman, Ph.D.

Fahrmann works in the lab of Dr. W. Elaine Hardman, a professor in the Department of Biochemistry and Microbiology. Valentovic will also be presenting at Experimental Biology. In that talk, she will discuss her work to examine the mechanisms for reducing cancer chemotherapy adverse effects to the kidney. That research was funded by the National Institutes of Health.

Also presenting at Experimental Biology 2012 will be M. Allison Wolf, a biomedical sciences doctoral candidate in the lab of Pier Paolo Claudio, M.D., Ph.D. She is disseminating her research on the anticancer effects of isothiocyanates, a natural compound extracted from cruciferous vegetables, on head and neck cancer. Her work shows that isothiocyanates both inhibit head and neck metastasis and greatly increase the sensitivity to chemotherapy in therapy-resistant head and neck cancers.

Nearly 14,000 scientists and exhibitors representing academic institutions, government agencies, non-profit organizations and private corporations attend the annual Experimental Biology meeting to share information about recent developments in anatomy, physiology, biochemistry, pathology, nutrition and pharmacology.

For more information, contact Valentovic at 304-696-7332 or valentov@marshall.edu, or Hardman at 304-696-7339 or hardmanw@marshall.edu.